SmellTaste is delighted that Dupilumab has been approved for eligible* NHS England patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP), a long-term inflammatory condition that has a profound impact on quality of life and is a leading cause of smell loss.
SmellTaste has been a s...